Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,411.20
(
-2.35%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,252.13
(
-0.13%
)
News Focus
News Focus
Post# of 257299
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: masterlongevity post# 120707

Saturday, 05/28/2011 9:31:34 AM

Saturday, May 28, 2011 9:31:34 AM

Post# of 257299
>In the same post-hoc, bapineuzumab did not show benefit over PBO on ANY measure in the carrier population<

Why would they do Phase 3 on a population that showed no benefit in Phase 2?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today